<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Transcranial magnetic stimulation evaluation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Transcranial magnetic stimulation evaluation</h1>
<div class="graphic"><div class="figure"><div class="ttl">Transcranial magnetic stimulation evaluation</div><div class="cntnt"><table cellspacing="0"><colgroup width="35%"></colgroup><colgroup width="65%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="2">Variables to assess before commencing rTMS</td> </tr> <tr> <td class="subtitle2">Variable</td> <td class="subtitle2">What to do if the variable is endorsed by the patient</td> </tr> <tr> <td> <ul> <li>History of epilepsy </li> <li>Family history of epilepsy </li> <li>History of seizure </li> <li>History of head trauma </li> <li>History of loss of consciousness </li> <li>History of stroke </li> <li>History of brain tumor </li> <li>History of traumatic brain injury </li> <li>Any implanted medical devices </li> <li>Any metal in the head </li> </ul> </td> <td> <ul> <li>Determine with the patient the risk/benefit ratio of administering rTMS given the presence of risk variables. </li> <li>Inform the patient that the presence of 1 or more of these variables could increase the risk of rTMS-associated adverse effects including a TMS-associated seizure. </li> <li>Consider consultation with other health care professionals (eg, neurologist) to assess risks of possible rTMS-associated adverse effects before commencing treatment with rTMS. </li> </ul> </td> </tr> <tr> <td> <ul> <li>Current use of medication(s) that lower seizure threshold </li> </ul> </td> <td> <ul> <li>Document the medications including the drug name and dose. Use the information to create an individualized medication checklist and update this list at each rTMS session. </li> <li>Encourage the patient and their psychiatric provider to keep medications stable during the rTMS course and to inform the rTMS clinical staff of any changes in medication use. </li> </ul> </td> </tr> <tr class="divider_bottom"> <td> <ul> <li>Current alcohol/substance use </li> </ul> </td> <td> <ul> <li>Document the type and amount of alcohol/substance consumed. </li> <li>Provide education on the effects of alcohol/substance use on rTMS. </li> </ul> </td> </tr> <tr> <td class="subtitle1" colspan="2">Variables to assess at each rTMS session</td> </tr> <tr> <td class="subtitle2">Variable</td> <td class="subtitle2">Actions or considerations</td> </tr> <tr> <td> <ul> <li>Sleep the night before treatment </li> </ul> </td> <td>If the patient endorses insomnia, then: <ul class="decimal_heading"> <li>Assess the duration and severity of the insomnia. </li> <li>Provide education on sleep hygiene. </li> <li>If warranted (new onset or significant change in sleep pattern), consider rechecking motor threshold before commencing with rTMS treatment. </li> </ul> </td> </tr> <tr> <td> <ul> <li>Any medication changes </li> </ul> </td> <td> <ul> <li>Document any medication changes and reconcile with the medication history before each treatment. </li> <li>Provide education to the patient that changes in medication could affect the motor threshold. </li> <li>If warranted (change in medication could alter seizure threshold), consider rechecking motor threshold before commencing with rTMS treatment. </li> </ul> </td> </tr> <tr> <td colspan="2"> <ul> <li>Side effects including: </li> </ul> </td> </tr> <tr> <td class="indent1">Headache associated with rTMS</td> <td> <ul> <li>Document the duration and severity of the headache. </li> <li>Provide reassurance and educate the patient that headaches tend to occur early in treatment and decrease with successive treatments. </li> <li>If appropriate, recommend over-the-counter analgesic medication. </li> <li>Instruct the patient to monitor the headache for resolution and report back to rTMS staff. </li> </ul> </td> </tr> <tr> <td class="indent1">Neck pain associated with rTMS</td> <td> <ul> <li>Document the duration and severity of neck pain. </li> <li>Adjust the patient's seating position and head position to enhance comfort. </li> <li>Provide neck support as needed (eg, pillow). </li> </ul> </td> </tr> <tr> <td class="indent1">Pain/discomfort at stimulation site (scalp)</td> <td> <ul> <li>Document the quality, duration, and severity of pain. </li> <li>Provide reassurance and education to the patient that pain at stimulation site tends to be transient. </li> <li>If appropriate, recommend over-the-counter analgesic medication. </li> <li>If appropriate, recommend or prescribe topical analgesic for application to scalp (eg, lidocaine gel). </li> <li>Make subtle adjustment to coil position. </li> <li>Slightly reduce magnetic field intensity. </li> <li>Instruct the patient to monitor the pain and report information at the subsequent rTMS session. </li> </ul> </td> </tr> <tr> <td class="indent1">Scalp induration/irritation from rTMS coil</td> <td> <ul> <li>Document the size and appearance of the erythema or edema at stimulation site on scalp. </li> <li>Provide education to the patient that redness is transient. </li> <li>Assess the coil temperature. </li> <li>Assess the coil contact on the scalp; adjust pressure if appropriate. </li> </ul> </td> </tr> <tr> <td class="indent1">Induction of manic/hypomanic symptoms</td> <td> <ul> <li>Monitor closely for treatment-emergent insomnia, anxiety, irritability, agitation; use standard mania assessment scales in susceptible individuals. </li> <li>Evaluate possible role of concurrent medications. </li> <li>Consider whether treatment with rTMS should be discontinued. </li> </ul> </td> </tr> <tr> <td class="indent1">Hearing loss/tinnitus</td> <td> <ul> <li>Assess for duration and severity of hearing loss/tinnitus in relation to rTMS sessions. </li> <li>Check that ear plugs are intact. </li> <li>Instruct the patient to monitor the hearing loss/tinnitus and report information to the rTMS staff. </li> <li>Refer the patient to an audiologist as needed. </li> </ul> </td> </tr> <tr> <td class="indent1">Vasovagal presyncope or syncope</td> <td> <ul> <li>Document the duration and severity of the symptoms. </li> <li>Reassure the patient that syncope is a possible, but rare side effect. </li> <li>Instruct the patient on adequate hydration prior to treatment. </li> <li>Monitor medication use associated with orthostatic hypotension. </li> <li>If the patient experiences syncope, stop the current rTMS session and adjust the patient's head to a downward position to increase cerebral perfusion. </li> <li>Check the patient's blood pressure and pulse before and after each treatment. </li> <li>Refer the patient to a health care provider (eg, primary care physician, cardiologist) as needed. </li> </ul> </td> </tr> <tr> <td class="indent1">Seizure</td> <td> <ul> <li>Stop the stimulation and remove the coil. </li> <li>Ensure the patient is safe and is breathing. </li> <li>Do not try to restrain the patient or put anything in the patient's mouth. </li> <li>When possible and the patient is safe, turn the patient to the side to minimize possible aspiration. </li> <li>When possible and the patient is safe, call emergency medical services (EMS). </li> <li>Document the seizure activity (including start and stop time). </li> <li>Discontinue treatment with rTMS pending medical evaluation. </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">rTMS: repetitive transcranial magnetic stimulation.</div><div class="graphic_reference">McClintock SM, Reti IM, Carpenter LL, et al. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression, The Journal of Clinical Psychiatry. Volume 79, Pages 35-48, 2018. Copyright 2020, Physicians Postgraduate Press. Reprinted by permission.</div><div id="graphicVersion">Graphic 130014 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
